Jim Byard's Health Beat
Potential Alzheimer's Drug Fails Trails


A drug company says its experimental Alzheimer's drug has hit a snag. The disease affects more than five-million Americans. Crenezumab, made by Swiss-based Roche Holding, did not improve either cognitive skills or memory in patients. The study also suggested doctors should start treating Alzheimer's early.

 «  Return to previous page
 »  Send to a friend
Subscribe to channel
On Air Now